ACTIVE

Futurophar

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

24,3 k €

-12.9% YoY

Gross margin

189,9 k €

-0.1% YoY

Equity

263,7 k €

+8.8% YoY

What does Futurophar do?

Futurophar is a Private limited company incorporated in 2008. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Gent.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0894.964.461

Incorporation

16/01/2008

Legal form

Private limited company

Registered office

Toekomststraat 49
9040 Gent · FlandreSee on map

Contributed capital

6 200,00 €

Latest accounts

31/12/2024

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 70200Management consultancy activities 70220Business and other management consultancy activities

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 16 financial years

	2024		2023		2022		2021		2020		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008
Income statement
Gross margin	189,9 k €	-0.1%	190 k €	+23.2%	154,2 k €	+11.8%	137,9 k €	+23.1%	112,1 k €	-37.2%	178,5 k €	+12.5%	158,6 k €	-26.8%	216,5 k €	+64.4%	131,7 k €	+165%	49,8 k €	-26.4%	67,7 k €	+14.9%	58,9 k €	+20.3%	48,9 k €	+0.1%	48,9 k €	+27.9%	38,2 k €	-0.4%	38,4 k €
EBITDA	59,8 k €	+1.0%	59,2 k €	+77.8%	33,3 k €	-19.4%	41,3 k €	+8.3%	38,2 k €	-67.3%	116,9 k €	+12.6%	103,8 k €	-34.9%	159,5 k €	+47.2%	108,3 k €	+213%	34,6 k €	-31.7%	50,6 k €	+13.9%	44,4 k €	-8.0%	48,3 k €	+0.2%	48,2 k €	+28.3%	37,6 k €	+0.8%	37,3 k €
Operating result	38,6 k €	-5.4%	40,8 k €	+64.5%	24,8 k €	-28.2%	34,6 k €	+19.4%	29 k €	-67.9%	90,3 k €	+45.5%	62,1 k €	-49.8%	123,7 k €	+48.4%	83,4 k €	+595%	12 k €	-55.6%	27 k €	+28.9%	20,9 k €	-17.1%	25,3 k €	+1.0%	25 k €	+59.4%	15,7 k €	-28.5%	21,9 k €
Net result	24,3 k €	-12.9%	28 k €	+64.1%	17 k €	-29.0%	24 k €	+9.4%	21,9 k €	-67.5%	67,5 k €	+69.2%	39,9 k €	-52.0%	83,1 k €	+62.1%	51,3 k €	+812%	5,6 k €	-66.0%	16,5 k €	+67.6%	9,9 k €	-9.1%	10,9 k €	+12.3%	9,7 k €	+288%	2,5 k €	-78.2%	11,4 k €
Balance sheet
Equity	263,7 k €	+8.8%	242,3 k €	+11.5%	217,4 k €	+7.0%	203,1 k €	+11.4%	182,3 k €	+89.7%	96,1 k €	-26.0%	129,8 k €	+42.3%	91,2 k €	+36.2%	66,9 k €	-3.9%	69,6 k €	+8.8%	64 k €	+34.8%	47,5 k €	+26.2%	37,6 k €	+40.5%	26,8 k €	+56.5%	17,1 k €	+17.1%	14,6 k €
Total assets	394,6 k €	+0.3%	393,5 k €	+29.8%	303 k €	+8.0%	280,6 k €	+11.6%	251,5 k €	-18.9%	310,2 k €	+20.8%	256,9 k €	-20.2%	322 k €	+31.3%	245,3 k €	+14.3%	214,6 k €	-14.5%	251,1 k €	-3.0%	258,9 k €	-5.1%	272,9 k €	-2.4%	279,6 k €	-2.4%	286,5 k €	+0.7%	284,5 k €
Cash	60,5 k €	+41.8%	42,7 k €	-32.9%	63,6 k €	-29.6%	90,4 k €	+67.6%	53,9 k €	-9.9%	59,8 k €	+375%	12,6 k €	-80.0%	62,9 k €	+0.3%	62,7 k €	+133%	26,9 k €	-30.0%	38,4 k €	+25.5%	30,6 k €	+29.3%	23,7 k €	+50.4%	15,7 k €	-19.1%	19,4 k €	-55.5%	43,7 k €
Debts	129,7 k €	-13.6%	150,1 k €	+76.6%	85 k €	+10.7%	76,8 k €	+12.1%	68,5 k €	-68.0%	214,1 k €	+69.0%	126,7 k €	-45.0%	230,6 k €	+29.3%	178,4 k €	+24.1%	143,7 k €	-23.2%	187,1 k €	-11.3%	210,9 k €	-10.3%	235 k €	-3.6%	243,7 k €	-6.9%	261,8 k €	-0.7%	263,7 k €
Other
Workforce	–		–		–		–		–		–		1,0 ETP	-16.7%	1,2 ETP	+200%	0,4 ETP	+33.3%	0,3 ETP	0.0%	0,3 ETP	0.0%	0,3 ETP		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 5 ended

Active mandates

Lamont Wim

Director · since 16 mars 2015

Active

Wauters VIRGINIE

Director · since 25 janvier 2008

Active

Ended mandates

Wim Lamont

Manager · since 19 mars 2015

Ended

Lamont Wim

Manager · since 16 mars 2015

Ended

Virginie Wauters

Manager · since 25 janvier 2008

Ended

Wim Lamont

Manager · since 25 janvier 2008

Ended

At this address

Other companies at this address

Company	CBE no.
Equinoxa Consulting● Active	0728.672.512

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/08/2025	26/08/2024	23/08/2023	26/08/2022	31/08/2021	30/08/2020
General meeting	06/03/2025	24/04/2024	15/03/2023	16/03/2022	28/05/2021	27/05/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

17 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2024	06/03/2025	22/08/2025	Dutch	PDF
Micro model	31/12/2023	24/04/2024	26/08/2024	Dutch	PDF
Micro model	31/12/2022	15/03/2023	23/08/2023	Dutch	PDF
Micro model	31/12/2021	16/03/2022	26/08/2022	Dutch	PDF
Micro model	31/12/2020	28/05/2021	31/08/2021	Dutch	PDF
Micro model	31/12/2019	27/05/2020	30/08/2020	Dutch	PDF
Micro model	31/12/2018	22/05/2019	27/08/2019	Dutch	PDF
Abridged model	31/12/2017	15/06/2018	16/07/2018	Dutch	PDF
Abridged model	31/12/2016	16/06/2017	25/07/2017	Dutch	PDF
Abridged model	31/12/2015	30/06/2016	28/08/2016	Dutch	PDF
Abridged model	31/12/2014	30/06/2015	31/08/2015	Dutch	PDF
Abridged model	31/12/2013	30/06/2014	24/08/2014	Dutch	PDF
Abridged model	31/12/2012	21/06/2013	16/07/2013	Dutch	PDF
Abridged model	31/12/2011	30/06/2012	25/07/2012	Dutch	PDF
Abridged model	31/12/2010	17/06/2011	14/07/2011	Dutch	PDF
Abridged model	31/12/2009	30/06/2010	23/07/2010	Dutch	PDF
Abridged model	31/12/2008	30/06/2009	23/07/2009	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 5 ended

Active mandates

Lamont Wim

Director · since 16 mars 2015

Active

Wauters VIRGINIE

Director · since 25 janvier 2008

Active

Ended mandates

Wim Lamont

Manager · since 19 mars 2015

Ended

Lamont Wim

Manager · since 16 mars 2015

Ended

Virginie Wauters

Manager · since 25 janvier 2008

Ended

Wim Lamont

Manager · since 25 janvier 2008

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates13/10/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
PDF
Mandates31/03/2015
BENAMING - ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Capital / shares12/01/2009
KAPITAAL - AANDELEN - DIVERSEN
PDF
Other25/01/2008
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 202424,3 k €↓
2024
Name changeFuturopharma
2023
Annual accounts 202328 k €↑
2023
Name changeFuturophar
2022
Annual accounts 202217 k €↓
2021
Annual accounts 202124 k €↑
2021
Name changeEquinoxa Advies
2020
Annual accounts 202021,9 k €↓
2018
Annual accounts 201867,5 k €↑
2017
Annual accounts 201739,9 k €↓
2016
Annual accounts 201683,1 k €↑
2015
Annual accounts 201551,3 k €↑
2014
Annual accounts 20145,6 k €↓
2013
Annual accounts 201316,5 k €↑
2012
Annual accounts 20129,9 k €↓
2011
Annual accounts 201110,9 k €↑
2010
Annual accounts 20109,7 k €↑
2009
Annual accounts 20092,5 k €↓
2008
Annual accounts 200811,4 k €
16/01/2008
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Futurophar

Overview

What does Futurophar do?

Trend over 16 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline